Denali Therapeutics shares owned by Principal Financial Group
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Principal Financial Group
from 13F filings
Historical chart of Principal Financial Group investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by Principal Financial Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Denali Therapeutics by Principal Financial Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $33M | 1.2M | 26.60 |
| 2024-06-30 | $25M | 1.1M | 23.22 |
| 2024-03-31 | $23M | 1.1M | 20.51 |
| 2023-12-31 | $23M | 1.1M | 21.46 |
| 2023-09-30 | $14M | 680k | 19.78 |
| 2023-06-30 | $20M | 687k | 29.51 |
| 2023-03-31 | $11M | 489k | 23.04 |
| 2022-12-31 | $15M | 527k | 27.81 |
| 2022-09-30 | $17M | 546k | 30.68 |
| 2022-06-30 | $7.9M | 268k | 29.43 |
| 2022-03-31 | $8.6M | 269k | 32.14 |
| 2021-12-31 | $15M | 330k | 44.60 |
| 2021-09-30 | $15M | 304k | 50.45 |
| 2021-06-30 | $26M | 329k | 78.44 |
| 2021-03-31 | $19M | 338k | 57.10 |
| 2020-12-31 | $17M | 208k | 83.76 |
| 2020-09-30 | $7.3M | 203k | 35.83 |
| 2020-06-30 | $4.9M | 202k | 24.18 |
| 2020-03-31 | $3.6M | 204k | 17.51 |
| 2019-12-31 | $3.9M | 225k | 17.42 |
| 2019-09-30 | $3.4M | 219k | 15.32 |
| 2019-06-30 | $4.6M | 220k | 20.76 |
| 2019-03-31 | $4.3M | 187k | 23.22 |
| 2018-12-31 | $3.8M | 186k | 20.66 |
| 2018-09-30 | $4.0M | 186k | 21.74 |
| 2018-06-30 | $2.8M | 183k | 15.25 |
| 2018-03-31 | $2.5M | 129k | 19.69 |
| 2017-12-31 | $2.8M | 181k | 15.64 |